Literature DB >> 30414744

Acute liver failure: A review for emergency physicians.

Tim Montrief1, Alex Koyfman2, Brit Long3.   

Abstract

INTRODUCTION: Acute liver failure (ALF) remains a high-risk clinical presentation, and many patients require emergency department (ED) management for complications and stabilization.
OBJECTIVE: This narrative review provides an evidence-based summary of the current data for the emergency medicine evaluation and management of ALF. DISCUSSION: While ALF remains a rare clinical presentation, surveillance data suggest an overall incidence between 1 and 6 cases per million people every year, accounting for 6% of liver-related deaths and 7% of orthotopic liver transplants (OLT) in the U.S. The definition of ALF includes neurologic dysfunction, an international normalized ratio ≥ 1.5, no prior evidence of liver disease, and a disease course of ≤26 weeks, and can be further divided into hyperacute, acute, and subacute presentations. There are many underlying etiologies, including acetaminophen toxicity, drug induced liver injury, and hepatitis. Emergency physicians will be faced with several complications, including encephalopathy, coagulopathy, infectious processes, renal injury, and hemodynamic instability. Critical patients should be evaluated in the resuscitation bay, and consultation with the transplant team for appropriate patients improves patient outcomes. This review provides several guiding principles for management of acute complications. Using a pathophysiological-guided approach to the management of ALF associated complications is essential to optimizing patient care.
CONCLUSIONS: ALF remains a rare clinical presentation, but has significant morbidity and mortality. Physicians must rapidly diagnose these patients while evaluating for other diseases and complications. Early consultation with a transplantation center is imperative, as is identifying the underlying etiology and initiating symptomatic care. Published by Elsevier Inc.

Entities:  

Keywords:  Acute liver failure; Liver function; Transplantation

Mesh:

Substances:

Year:  2018        PMID: 30414744     DOI: 10.1016/j.ajem.2018.10.032

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

1.  Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice.

Authors:  Wenwen Mu; Qi Wang; Mingxia Jia; Sijia Dong; Sijie Li; Jie Yang; Guoyun Liu
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

2.  Luzindole attenuates LPS/d-galactosamine-induced acute hepatitis in mice.

Authors:  Yisheng Luo; Yongqiang Yang; Yi Shen; Longjiang Li; Jiayi Huang; Li Tang; Li Zhang
Journal:  Innate Immun       Date:  2019-11-28       Impact factor: 2.680

3.  Analysis of weekend effect in severe acute liver injury: A nationwide database study.

Authors:  Albert Do; Ysabel C Ilagan-Ying; Tamar H Taddei
Journal:  Health Sci Rep       Date:  2019-11-22

4.  A Comparative Study of the Hepatoprotective Effect of Centella asiatica Extract (CA-HE50) on Lipopolysaccharide/d-galactosamine-Induced Acute Liver Injury in C57BL/6 Mice.

Authors:  Woojae Hong; Jeon Hwang-Bo; Hyelin Jeon; Minsung Ko; Joongyeon Choi; Yong-Joon Jeong; Jae-Hyun Park; Inhye Kim; Tae-Woo Kim; Hyunggun Kim; Se-Chan Kang
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

5.  Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.

Authors:  Naresh Naik Ramavath; Laila Lavanya Gadipudi; Alessia Provera; Luca C Gigliotti; Elena Boggio; Cristina Bozzola; Emanuele Albano; Umberto Dianzani; Salvatore Sutti
Journal:  Front Immunol       Date:  2021-12-03       Impact factor: 7.561

6.  Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.

Authors:  Christoph Zechner; Beverley Adams-Huet; Blake Gregory; Javier A Neyra; Jody A Rule; Xilong Li; Jorge Rakela; Orson W Moe; William M Lee
Journal:  Transl Res       Date:  2021-07-21       Impact factor: 7.012

7.  Systemic quinolones and risk of acute liver failure III: A nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  J Gastroenterol Hepatol       Date:  2021-03-31       Impact factor: 4.029

8.  Safety and efficacy of mesotherapy in musculoskeletal disorders: A systematic review of randomized controlled trials with meta-analysis.

Authors:  Lorenzo Faetani; Daniele Ghizzoni; Antonio Ammendolia; Cosimo Costantino
Journal:  J Rehabil Med       Date:  2021-04-27       Impact factor: 2.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.